Through a grant awarded by NIH National Center for Advancing Translational Science, the UNM HSC Clinical and Translational Science Center has developed innovative programs to improve the efficiency, quality, and impact for turning explorations from our laboratories, clinics, and community into interventions that improve the health of individuals and the public.
Provides many resources to help academic and community stakeholders form mutually beneficial partnerships for effective clinical and translational research
The DDRC collaborates with other universities and the National Center for Advancing Translational Sciences to improve health outcomes by providing unique resources for rapidly translating existing drugs for use in new clinical trials.
Meaningfully engages and integrates special populations across the lifespan in all aspects of CTR, as well as to provide a comprehensive means to support participant and clinical interactions.
The KL2 program equips a cohort of independent faculty with the training and support needed to conduct exceptional clinical and translational research.
Provides innovative solutions to enhance participation and collaboration in clinical and translational research.
OPIOIDD’s objective is to enhance and expand UNM HSC services to catalyze opioid-related CTR in New Mexico, a state which is disproportionately impacted by the opioid-crisis.
Provides a coordinated platform for consultation and training programs for clinical and translational research.
Provides academic support and resources supporting investigators and their research teams
|
Cite the Grant: This project is supported by an award from the National Center for Advancing Translational Sciences, National Institutes of Health under grant number UL1TR001449. Link the Grant: To your publication in NCBI My Bibliography (Pandhi & Campen, PIs) |